About Terrace Pharmaceuticals
Terrace Pharmaceuticals is a company based in Sahibzada Ajit Singh Nagar (India) founded in 2007. It operates as a B2B and D2C. The company has 5 employees as of March 31, 2024. Terrace Pharmaceuticals offers products and services including Pharmaceutical Drugs, MEFRO PHARMACEUTICALS, and Cyril Pharmaceuticals. Terrace Pharmaceuticals operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
- Headquarter Sahibzada Ajit Singh Nagar, India
- Employees 5 as on 31 Mar, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Terrace Pharmaceuticals Private Limited
- Date of Incorporation 11 Nov, 2005
- Jurisdiction S.A.S.Nagar (Mohali), Punjab, India
-
Annual Revenue
$4.76 M (USD)38.7as on Mar 31, 2024
-
Net Profit
$30.69 K (USD)39.62as on Mar 31, 2024
-
EBITDA
$358.49 K (USD)-47.24as on Mar 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
5
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Terrace Pharmaceuticals
Terrace Pharmaceuticals offers a comprehensive portfolio of products and services, including Pharmaceutical Drugs, MEFRO PHARMACEUTICALS, and Cyril Pharmaceuticals.
Manufactures tablets, capsules, and other drugs for medical use
Focuses on pharmaceutical formulations and production
Handles specific pharmaceutical product lines and innovations
Funding Insights of Terrace Pharmaceuticals
Detailed funding history for Terrace Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Terrace Pharmaceuticals
Investment portfolio details for Terrace Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Terrace Pharmaceuticals
Detailed financials for Terrace Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Terrace Pharmaceuticals Comparisons
Peer comparison for Terrace Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Terrace Pharmaceuticals
Terrace Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
Detailed competitors of Terrace Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Terrace Pharmaceuticals
Complete news archive for Terrace Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Terrace Pharmaceuticals
Terrace Pharmaceuticals was founded in 2007.
Terrace Pharmaceuticals is headquartered in Sahibzada Ajit Singh Nagar, India. It is registered at Sahibzada Ajit Singh Nagar, Punjab, India.
As of Mar 31, 2024, the latest employee count at Terrace Pharmaceuticals is 5.
Annual revenue of Terrace Pharmaceuticals is $4.76M as on Mar 31, 2024.
Terrace Pharmaceuticals, established in 2007, produces a wide range of pharmaceutical items like tablets and capsules through its manufacturing units in Mohali, Punjab, and Himachal Pradesh, India. The company focuses on speciality divisions such as MEFRO PHARMACEUTICALS and Cyril Pharmaceuticals, maintaining a national network and global presence. It engages in institutional business and contract manufacturing, serving various clients in the healthcare sector with advanced facilities connected by major highways.
Terrace Pharmaceuticals's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Terrace Pharmaceuticals offers Pharmaceutical Drugs, MEFRO PHARMACEUTICALS, and Cyril Pharmaceuticals.